Mcl-1
January 31, 2020
Senescence-associated beta-galactosidase (SA-β-gal or SABG)
February 10, 2020
Neuroprotective effects of flavonoids and polyphenols
- A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders
- A bird’s-eye view of the multiple biochemical mechanisms that propel pathology of Alzheimer’s disease: recent advances and mechanistic perspectives on …
- A blueberry extract-supplemented diet rescues phenotypes in drosophila melanogaster models of parkinson disease
- A Comparative Study on the Phenolic Composition and Biological Activities of Morus alba L. Commercial Samples
- A Comparison of the Antioxidant Activity with the Total Phenolic and Total flavonoid contents of the Leaves and Stem-bark of Anogeissus leiocarpa (DC.) Guill& Pirr …
- A comprehensive database and analysis framework to incorporate multiscale data types and enable integrated analysis of bioactive polyphenols
- A comprehensive review on phytochemistry, pharmacology, and flavonoid biosynthesis of Scutellaria baicalensis
- A Current Understanding of Alzheimer’s Disease and the Prospects of Phytopharmacological Intervention as a Management Strategy
- A meta-analysis of tea drinking and risk of Parkinson’s disease
- A molecular approach in drug development for Alzheimer’s disease
- A Narrative Review of Lifestyle Factors Associated with Parkinson’s Disease Risk and Progression
- A Novel GSK3β Inhibitor Reduces Tau Pathology in Alzheimer’s Disease
- A Paradigm Shift to Prevent and Treat Alzheimer’s Disease: From Monotargeting Pharmaceuticals to Pleiotropic Plant Polyphenols
- A pharmacological appraisal of neuroprotective and neurorestorative flavonoids against Neurodegenerative diseases
- A review of antioxidant and pharmacological properties of phenolic compounds in Acacia confusa
- A Review of Antioxidants and Alzheimer
- A review of antioxidants and Alzheimer’s disease
- A review of genome mutation and Alzheimer’s disease
- A review on cholinesterase inhibitors for Alzheimer’s disease
- A Review on Current Strategies and Future Perspective in Respect to Alzheimer’s Disease Treatment
- A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer’s and Parkinson’s diseases
- A Review on Medicinal Plants for Alzheimer’s disease
- A review on mitochondrial restorative mechanism of antioxidants in Alzheimer’s disease and other neurological conditions
- A review on potential mechanisms of Terminalia chebula in Alzheimer’s disease
- A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer’s disease
- A review on the beneficial effects of tea polyphenols on human health
- A review on the status of the phenolic compounds and antioxidant capacity of the flour: Effects of cereal processing
- A review–probable mechanism of action of curcumin for the treatment of Alzheimer disease (AD)
- A review: inflammatory process in Alzheimer’s disease, role of cytokines
- A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer’s disease mouse model
- A Study on the Role of Mimosa Pudica (Thottar Chinungi) on the Experimental Models of Parkinsonism (Nadukku Vatham)
- A synopsis on the linkage between age-related dementias and vascular disorders
- A systematic review on the role of natural products in modulating the pathways in Alzheimer’s disease
- Acacetin—A simple flavone exhibiting diverse pharmacological activities
- Accumulation of citrus flavanones in bovine milk following citrus pulp incorporation into the diet of dairy cows
- Acetyl-cholinesterase Inhibition by Extracts and Isolated Flavones from Linaria reflexa Desf. (Scrophulariaceae)
- Acetylated flavonoid Glycosides Potentiating NGF Action from Scoparia dulcis
- Activation of pro‐survival Akt and ERK1/2 signalling pathways underlie the anti‐apoptotic effects of flavanones in cortical neurons
- Acute effects of flavonoid-rich blueberry on cognitive and vascular function in healthy older adults
- Adult‐onset brain tumors and neurodegeneration: Are polyphenols protective?
- Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer’s disease
- Advances in multi-functional ligands and the need for metal-related pharmacology for the management of Alzheimer disease
- Advances in research on active constituents of Chinese materia medica in treatment of Alzheimer’s disease [J]
- Agathisflavone, a flavonoid derived from Poincianella pyramidalis (Tul.), enhances neuronal population and protects against glutamate excitotoxicity
- Age-related cognitive impairment as a sign of geriatric neurocardiovascular interactions: may polyphenols play a protective role?
- Aging risk factors and Parkinson’s disease: contrasting roles of common dietary constituents
- Alcohol Consumption in Predementia and dementia Syndromes
- Alcohol intake and risk of dementia
- Alcohol, wine and mental health: focus on dementia and stroke
- Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Göteborg
- Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer’s disease: A neuropharmacological review of their bioactive constituents
- Alpha-secretase ADAM10 regulation: insights into Alzheimer’s disease treatment
- Alpha-Synuclein and synuceinopathies as related to Parkinson’s disease
- Alpha-synuclein oligomers—neurotoxic molecules in Parkinson’s disease and other Lewy body disorders
- Altered Micro-RNA Regulation and Neuroprotection Activity of Eremostachys labiosiformis in Alzheimer’s Disease Model
- Alzheimer’s and Parkinson’s Disease Novel Therapeutic Target: The Mitochondrial Pyruvate Carrier-Ligand Docking to Screen Natural Compounds Related to Classic …
- Alzheimer’s Dementia: Can It Be Prevented?
- Alzheimer’s disease (AD) genes: Enrichment in cancer genes and those related to comorbid conditions, risk factors (pollution and pathogens) or beneficial agents …
- Alzheimer’s Disease & Treatment
- Alzheimer’s Disease & Treatment
- Alzheimer’s Disease & Treatment
- Alzheimer’s Disease & Treatment, Vol. 1
- Alzheimer’s disease and antioxidant therapy: how long how far?
- Alzheimer’s disease and its current treatments; Is there a possibility for a cure
- Alzheimer’s Disease and Metal Contamination: Aspects on Genotoxicity
- Alzheimer’s disease and natural products: Future regimens emerging from nature
- Alzheimer’s disease and other Neurodegenerative disorders
- Alzheimer’s Disease and Oxidative Stress
- Alzheimer’s Disease and Parkinson’s Disease: A Nutritional Toxicology Perspective of the Impact of Oxidative Stress, Mitochondrial Dysfunction, Nutrigenomics and …
- Alzheimer’s Disease and the Main Aspects-Literature Review
- Alzheimer’s DISEASE AND THE MICROBIOME
- Alzheimer’s disease as oligomeropathy
- Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
- Alzheimer’s Disease Theranostics
- Alzheimer’s disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
- Alzheimer’s Disease, Drosophila melanogaster and Polyphenols
- Alzheimer’s disease, neuroinflammation and the influence of different combinations of nutrients
- Alzheimer’s disease: A challenge in managing with certain medicinal plants-Areview
- Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL …
- Alzheimer’s Disease: An Approach for Non-Pharmacological Therapies
- Alzheimer’s disease: biological aspects, therapeutic perspectives and diagnostic tools
- Alzheimer’s Disease: Early Diagnosis & Fundamental Therapeutics
- Alzheimer’s disease: from pathology to therapeutic approaches
- Alzheimer’s disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms
- Alzheimer’s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the …
- Alzheimers Disease & Parkinsonism
- Ameliorating effect of ethanol leaf extract of Ficus hispida Linn. on amyloid beta Aβ (25-35) induced cognitive deficits and oxidative stress in Alzheimer’s mice
- Amelioration of 6-Hydroxydopamine-Lesion Induced Neurotoxicity by Different Extracts of Ocimum sanctum Leaves in Rodent Model of Parkinson’s Disease
- Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimer’s type
- Amentoflavone Ameliorates Aβ1–42-Induced Memory Deficits and oxidative stress in Cellular and Rat Model
- Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson’s disease model mice through PI3K/Akt and ERK signaling pathways
- Amentoflavone suppresses amyloid β1–42 neurotoxicity in Alzheimer’s disease through the inhibition of pyroptosis
- AMP‐activated protein kinase: a potential player in Alzheimer’s disease
- Amyloid A-Beta Peptide: In-Cell Studies and Mechanism of Polyphenol-Based Inhibition to Aggregation
- Amyloid precursor protein‐mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer’s disease
- Amyloid β-Peptide (1–42)-Induced oxidative stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression
- Amyloid β-protein assembly as a therapeutic target of Alzheimer’s disease
- Amyloid‐β deposition in Alzheimer transgenic mice is associated with oxidative stress
- An alternative approach to drug discovery for Alzheimer’s disease dementia
- An Evaluation of Cholesterol-lowering Effect of Soy Protein and Isoflavones on Postmenopausal Women and Hypercholesterolemic Humans.
- An Overview of Parkinson’s Disease and Oxidative Stress: Herbal Scenario
- An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer’s disease
- An overview on global trends in nanotechnological approaches for Alzheimer therapy
- An overview on potential neuroprotective compounds for management of Alzheimer’s disease
- An overview on therapeutics attenuating amyloid β level in Alzheimer’s disease: Targeting neurotransmission, inflammation, oxidative stress and enhanced …
- An update on plant-originated treatment for Alzheimer’s disease
- An updated review on Anti-Alzheimer’s herbal drugs
- Analgesic and acetylcholinesterase inhibition potential of polyphenols from Scolopia crenata (Flacourtiaceae): An endemic medicinal plant of India
- Analysis of amino acid and phenolic content in honey by UPLC-ESI-MS/MS
- Analysis of technological developments in the treatment of Alzheimer’s disease through patent documents
- Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson’s Disease
- Anesthesia Implications of the Use of Essential Oils in Alzheimer’s Dementia
- Animal models of Parkinson’s disease: a gateway to therapeutics?
- Anthocyanins Potentially Contribute to Defense against Alzheimer’s Disease
- Anthocyanins restore behavioral and biochemical changes caused by streptozotocin-induced sporadic dementia of Alzheimer’s type
- Anti-acetylcholinesterase and antioxidant activities and HPLC-MS analysis of polyphenol from extracts of Nelsonia canescens (Lam.) Spreng.
- Anti-adipogenic Effect of a Dietary flavonoid Fisetin in 3T3-L1 Cells
- Anti-aging and anti-aggregation properties of polyphenolic compounds in C. elegans
- Anti-Alzheimer potential of Green Moong Bean
- Anti-Alzheimer’s studies on β-sitosterol isolated from Polygonum hydropiper L.
- Anti-amnesic Effect of Leea indica Extract in Scopolamine-induced Amnesia of Alzheimer’s Type in Rats
- Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer’s β-amyloid fibrils in vitro
- Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer’s disease
- Anti-amyloidogenic properties of some phenolic compounds
- Anti-Demential Effect of EGB 761 on dementia Induced Wistar Rats
- Anti-Inflammatory Agents in Parkinson’s Disease
- Anti-inflammatory and immune therapy for Alzheimer’s disease: current status and future directions
- Anti-inflammatory and immunomodulatory properties of dietary flavonoids
- Anti-inflammatory Effects of flavonoid Compounds on TNBS-induced Acute Colitis in Rats
- Anti-inflammatory effects of flavonoids in Neurodegenerative disorders
- Anti-inflammatory Effects of O-methylated Flavonoid
- Anti-inflammatory, anti-diabetic, and anti-Alzheimer’s effects of prenylated flavonoids from Okinawa propolis: an investigation by experimental and computational …
- Anti-inflammatory, immunomodulatory, and prebiotic properties of dietary flavonoids
- Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer’s disease
- Anti-Parkinson potential of silymarin: mechanistic insight and therapeutic standing
- Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models?
- Antiaging Interventions: An Insight into Polyphenols and Brain Aging
- Antiapoptotic role of Agaricus blazei extract in rodent model of Parkinson’s disease
- Antidementic activity of Brassica oleracea l. var. Italica (brassicaceae) flower on memory deficit in young male rats
- Antidepressant flavonoids and their relationship with oxidative stress
- Antihepatotoxic, nephroprotective, and antioxidant activities of phenolic compounds from Satureja macrostema leaves against carbon tetrachloride-induced hepatic …
- Antioxidant activity and total phenolic content of ethanolic extract of Caesalpinia bonducella seeds
- Antioxidant activity of selected phenols estimated by ABTS and FRAP methods.
- Antioxidant Activity of Wine Polyphenols for Alzheimer Prevention
- Antioxidant and anti‐inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental …
- Antioxidant and Anticholinesterase Activities of Macrosphyra Longistyla (DC) Hiern Relevant in the Management of Alzheimer’s Disease
- Antioxidant and Choline Esterase Inhibitory Activity of Phenolic Rich Extracts from Bombax ceiba L. Flowers.
- Antioxidant and neuroprotective Effects of Synthetic Curcumin Analogues and Natural Phenolics
- Antioxidant and neuroprotective properties of blueberry polyphenols: a critical review
- Antioxidant and pro-oxidant effects of polyphenolic compounds and structure-activity relationship evidence
- Antioxidant Capacity and Behavioral Relevance of a Polyphenolic Extract of Chrysanthellum americanum in a Rat Model of Irritable Bowel Syndrome
- Antioxidant Capacity is Decreased in Alzheimer’s Disease and Mild Cognitive Impairment Patients
- ANTIOXIDANT EFFECT OF flavonoids IN Neurodegenerative DISEASES.
- Antioxidant effect of flavonoids present in Euterpe oleracea Martius and Neurodegenerative diseases: A literature review
- Antioxidant neuroprotection in Alzheimer’s disease as preventive and therapeutic approach
- Antioxidant Nutraceuticals and Parkinson’s Disease
- Antioxidant phenolic constituents from Parthenocissus tricuspidata
- Antioxidant plant polyphenols and cognitive disorders
- ANTIOXIDANT PROPERTIES OF A Ginkgo biloba LEAF EXTRACT (EGb 761) IN ANIMAL MODELS OF Alzheimer’s AND Parkinson’s DISEASES.
- Antioxidant properties of Crocus sativus L. and its constituents and relevance to Neurodegenerative diseases; focus on Alzheimer’s and Parkinson’s disease
- Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer’s disease
- Antioxidant therapy in Alzheimer’s disease: theory and practice
- Antioxidants and Alzheimer’s disease: from bench to bedside (and back again)
- Antioxidants and dementia risk: consideration through a cerebrovascular perspective
- Antioxidants as a potential therapy against age-related Neurodegenerative diseases: amyloid beta toxicity and Alzheimer’s disease
- Antioxidants in the Prevention and Treatment of Alzheimer’s Disease
- Antioxidants, diet, polyphenols and dementia
- Apolipoprotein ε-4 as a genetic determinant of Alzheimer’s disease heterogeneity
- Apples and their products effect on neurodegeneration and Alzheimer’s disease
- Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer’s disease
- Applying Epigenetics to Alzheimer’s Disease via the Latent Early–life Associated Regulation (LEARn) Model
- Applying transcriptomic and proteomic knowledge to Parkinson’s disease drug discovery
- Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
- Are polyphenols strong dietary agents against neurotoxicity and neurodegeneration?
- Arecanut (Areca catechu L) decreases Alzheimer’s disease symptoms: Compilation of research works
- Artemisia amygdalina Upregulates Nrf2 and Protects Neurons Against oxidative stress in Alzheimer Disease
- Asparagus cochinchinensis stimulates release of nerve growth factor and abrogates oxidative stress in the Tg2576 model for Alzheimer’s disease
- Assessment of anticholinesterase activities and antioxidant potentials of Anisomeles indica relevant to the treatment of Alzheimer’s disease
- Assessment of the effect of selected African plants on an in vitro model of Parkinson’s disease
- association of tea consumption with risk of Alzheimer’s disease and anti-beta-amyloid effects of tea
- ATR-IR study of the mechanism of aluminum chloride induced Alzheimer’s disease; curative and protective effect of Lipidium sativum water extract on …
- Attention-deficit/
hyperactivity disorder–unifying mechanism involving antioxidant therapy: Phenolics, reactive oxygen species, and oxidative stress - Attenuation of iNOS and COX2 by blueberry polyphenols is mediated through the suppression of NF-κB activation
- Auraptene Mitigates Parkinson’s Disease-Like Behavior by Protecting Inhibition of Mitochondrial Respiration and Scavenging Reactive Oxygen Species
- Autophagy in Alzheimer’s disease and promising modulatory effects of herbal medicine
- Autophagy, polyphenols and healthy ageing
- Aβ propagation and strains: implications for the phenotypic diversity in Alzheimer’s disease
- BACE inhibitors as potential therapeutics for Alzheimer’s disease
- BACE1 (β-secretase) inhibitors for the treatment of Alzheimer’s disease
- Baicalein reduces β‐amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer’s disease transgenic mouse model
- Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease
- Behavioral and neurochemical alterations induced by vanillin in a mouse model of Alzheimer’s disease
- Beneficial effect of flavone derivatives on Aβ-induced memory deficit is mediated by peroxisome proliferator-activated receptor γ coactivator 1α: a comparative study
- Beneficial effect of the flavonoid luteolin on neuroinflammation
- Beneficial effects of flavonoids against Parkinson’s disease
- Beneficial Effects of flavonoids on Neurological Disorders
- Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson’s disease: the role of glia and NRf2 regulation
- Beneficial effects of natural phenolics on levodopa methylation and oxidative neurodegeneration
- Beneficial effects of phenolic compounds from fruit and vegetables in Neurodegenerative diseases
- Beneficial effects of polyphenols on chronic diseases and ageing
- Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation
- Benefits from dietary polyphenols for brain aging and Alzheimer’s disease
- Berry phenolics and their antioxidant activity
- Beta amyloid aggregation inhibitors: small molecules as candidate drugs for therapy of Alzheimer’s disease
- Beyond antioxidants: the cellular and molecular interactions of flavonoids and how these underpin their actions on the brain
- Biflavonoids as potential small molecule therapeutics for Alzheimer’s disease
- Bioactive composition and promising health benefits of natural food flavors and colorants: potential beyond their basic functions
- Bioactive flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers-Implications for Parkinson’s Disease
- Bioactivity of olive oil phenols in neuroprotection
- Bioanalytical Approach to the Interaction of Novel sym-Triazine Derivatives with Alzheimer’s Disease Biomarkers
- Bioanalytical Approaches to Investigate Antioxidant Molecules and Nucleic Acid-Protein Interactions in Alzheimer’s Disease
- Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts
- Bioavailability and pharmaco-therapeutic potential of luteolin in overcoming Alzheimer’s disease
- Bioavailability of dietary polyphenols: Factors contributing to their clinical application in CNS diseases
- Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update
- Biochanin-A ameliorates behavioural and neurochemical derangements in cognitive-deficit mice for the betterment of Alzheimer’s disease
- Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis
- Biological reactivity of polyphenolic− glutathione conjugates
- Biopharmaceutical Monotargeting versus ‘Universal Targeting’of Late-Onset Alzheimer’s Disease Using Mixtures of Pleiotropic Natural Compounds
- Biophenols pharmacology against the amyloidogenic activity in Alzheimer’s disease
- Biophenols: Enzymes (β-secretase, Cholinesterases, histone deacetylase and tyrosinase) inhibitors from olive (Olea europaea L.)
- Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from …
- Bioprocessing Strategies to Enhance L-DOPA and Phenolic Bioactives in the Fava Bean (Vicia Faba)
- Biosynthesized metal nanoparticles as potential Alzheimer’s disease therapeutics
- Black tea theaflavins inhibit formation of toxic amyloid-β and α-synuclein fibrils
- Blanching alters the phenolic constituents and in vitro antioxidant and anticholinesterases properties of fireweed (Crassocephalum crepidioides)
- Blueberry polyhphenols and neuroprotection
- Blueberry polyphenols and neuroprotection
- Botanical phenolics and brain health
- Botanics: a potential source of new therapies for Alzheimer’s disease
- Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer’s disease
- Brain food for Alzheimer-free ageing: focus on herbal medicines
- Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease
- Brain iron accumulation in Parkinson’s disease: An investigation of genes related to iron metabolism and homeostasis and dietary behavior data in a case …
- Brain iron metabolism dysfunction in Parkinson’s disease
- Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson’s disease
- C0550 Neuroinflammation in Alzheimer’s Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals
- Caffeic acid attenuates oxidative stress, learning and memory deficit in intra-cerebroventricular streptozotocin induced experimental dementia in rats
- Can co-activation of Nrf2 and neurotrophic signaling pathway slow Alzheimer’s disease?
- Can consuming flavonoids restore old microglia to their youthful state?
- Can we prevent Parkinson’s disease
- Cannabis Flavonoids—Antioxidant & Anti-Inflammatory Benefits
- Carbohydrates and Glycomimetics in Alzheimer’s Disease Therapeutics and Diagnosis
- Carbon nanomaterials and amyloid beta interactions: Possible potentials in the detection and treatment of Alzheimer’s disease
- Catechin polyphenols: neurodegeneration and neuroprotection in Neurodegenerative diseases
- Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG)
- Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐
gallate: implications for Neurodegenerative diseases - Cellular and molecular aspects of Parkinson treatment: future therapeutic perspectives
- Cellular and molecular mechanisms of antioxidants in Parkinson’s disease
- Cellular phenotypes as inflammatory mediators in Parkinson’s disease: interventional targets and role of natural products
- Cerebral area differential redox response of neonatal rats to selenite-induced oxidative stress and to concurrent administration of highbush blueberry leaf polyphenols
- Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer’s …
- Challenges for research on polyphenols from foods in Alzheimer’s disease: bioavailability, metabolism, and cellular and molecular mechanisms
- Champagne wine polyphenols protect primary cortical neurons against peroxynitrite-induced injury
- Changing paradigm from one target one ligand towards multi-target directed ligand design for key drug targets of Alzheimer disease: an important role of in silico …
- Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar‐Affinity Copper Binding Site on Amyloid β1‐42
- Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar‐Affinity Copper Binding Site on Amyloid β1‐42
- Characterization of neurotoxic effects of NMDA and the novel neuroprotection by phytopolyphenols in mice.
- Characterization of phenolic compounds using UPLC–HRMS and HPLC–DAD and anti-cholinesterase and anti-oxidant activities of Trifolium repens L. leaves
- CHARACTERIZATION OF THE neuroprotective ACTIVITY OF THE polyphenol (-)-EPIGALLOCATECHIN-3-GALLATE IN THE BRAIN
- Charnoly body as a novel biomarker of nutritional stress in Alzheimer’s Disease
- Chemical fingerprint of Bacopa monnieri L. and Rosmarinus officinalis L. and their neuroprotective activity against Alzheimer’s disease in rat model’s putative …
- Chemical structures, bioactivities and molecular mechanisms of citrus polymethoxyflavones
- Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson’s disease
- Chocolate and the brain: neurobiological impact of cocoa flavanols on cognition and behavior
- Chocolate/Cocoa Polyphenols and Oxidative Stress
- Cholinesterase inhibitors as Alzheimer’s therapeutics
- Chroman-like cyclic prenylflavonoids promote neuronal differentiation and neurite outgrowth and are neuroprotective
- Chronic dietary supplementation of 4% figs on the modification of oxidative stress in Alzheimer’s disease transgenic mouse model
- Chronic Hypoxia Alters mRNA Expression of the Genes Related to Alzheimer’s Disease in Primary Neuronal Cells
- Chronic neuroinflammation in Alzheimer’s disease: new perspectives on animal models and promising candidate drugs
- Chronic treatment with resveratrol, a natural polyphenol found in grapes, alleviates oxidative stress and apoptotic cell death in ovariectomized female rats subjected to …
- Cinnamon, a promising prospect towards Alzheimer’s disease
- Citrus Fruit Polyphenols and Flavonoids: Applications to Psychiatric Disorders
- Clinical benefit and preservation of flavonols in dark chocolate manufacturing
- Clinical Development of a Novel Parkinsonian Drug in USA
- Cocoa and dark chocolate polyphenols: from biology to clinical applications
- Cocoa flavanols, exercise and the brain
- Cocoa Powder Triggers neuroprotective and Preventive Effects in a Human Alzheimer 0 s Disease Model by Modulating BDNF Signaling Pathway
- Cocoa powder triggers neuroprotective and preventive effects in a human Alzheimer’s disease model by modulating BDNF signaling pathway
- Coffee phenolic phytochemicals and kaempferol protect against oxidative damage of neuronal cells and memory impairments
- Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: a systematic review
- Cognitive Function and Consumption of Fruit and Vegetable Polyphenols in a Young Population: Is There a Relationship?
- Cognitive stimulation with leisure activities for prevention of cognitive decline and dementia: The aktiva study
- Cognitive-enhancing effect of quercetin in a rat model of Parkinson’s disease induced by 6-hydroxydopamine
- Combating oxidative stress disorders with citrus flavonoid: Naringenin
- Combination of EPA with carotenoids and polyphenol synergistically attenuated the transformation of microglia to M1 phenotype via inhibition of NF-κB
- Commentary: The flavonoid Baicalein Rescues Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer’s Disease
- Comparative analysis of total phenolic and total flavonoid contents, rutin, tannins and antioxidant capacity in Apiaceae and Lamiaceae families
- Comparative antioxidant activity of twenty traditional Indian medicinal plants and its correlation with total flavonoid and phenolic content
- Comparative evaluation of Helichrysi flos herbal extracts as dietary sources of plant polyphenols, and macro-and microelements
- Comparative evaluation of the antioxidant and anti-Alzheimer’s disease potential of coumestrol and puerarol isolated from pueraria lobata using molecular modeling …
- Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer’s disease and some pro-oxidant induced oxidative …
- Comparison of protective effects of four polyphenols on neuropathology and behavior of APP/PS1-21 transgenic mice, a model of Alzheimer’s disease
- Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01
- Complementary Therapies for Parkinson’s Disease: What’s Promoted, Rationale, Potential Risks and Benefits
- Compositional Changes in Anthocyanins, Flavonols, and Ellagitannins in Processed Blackberries
- Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
- Computational approaches to the investigation of proteins involved in Parkinson’s Disease
- Computational modeling of multi-target-directed inhibitors against Alzheimer’s disease
- Computer-aided structure-based design of multitarget leads for Alzheimer’s disease
- Conjugates of catecholamines with cysteine and GSH in Parkinson’s disease: possible mechanisms of formation involving reactive oxygen species
- Conservative iron chelation for Neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
- Considerations for the use of polyphenols as therapies in Neurodegenerative diseases
- Consumption of anthocyanin-rich cherry juice for 12 weeks improves memory and cognition in older adults with mild-to-moderate dementia
- Consumption of fig fruits grown in Oman can improve memory, anxiety, and learning skills in a transgenic mice model of Alzheimer’s disease
- Consumption of polyphenol plants may slow aging and associated diseases
- Contribution of Intracellular Non-Haem Iron, NF-kB Activation and Inflammatory Responses to Neurodegeneration in Parkinson’s Disease: Prospects for …
- Contribution of Intracellular Non-Haem Iron, NF-kB Activation and Inflammatory Responses to Neurodegeneration in Parkinson’s Disease: Prospects for …
- Copper-Catalyzed Oxidative Esterification of 2-Carbonyl Substituted Phenols with Alcohols
- Correlation between the polyphenol content and antioxidant effect of Cynara scolymus L. mother tincture
- Critical Evaluation of Current Alzheimer′ s Drug Discovery (2018-19) & Futuristic Alzheimer drug model approach
- Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson’s disease
- Curcumin and Apigenin–novel and promising therapeutics against chronic neuroinflammation in Alzheimer’s disease
- Curcumin and Its Nanoformulations as Therapeutic for Alzheimer’s Disease
- Curcumin exposure induces expression of the Parkinson’s disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells
- Curcumin has potent anti‐amyloidogenic effects for Alzheimer’s β‐amyloid fibrils in vitro
- Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer’s disease animal models
- Curcumin prevents and ameliorates biochemical and behavioral toxicities of MPTP in C57Bl/6J mice: its potential use in preventing and treating parkinsonism
- Curcumin-glucoside, a novel synthetic derivative of curcumin, inhibits α-synuclein oligomer formation: relevance to Parkinson’s disease
- Current Alzheimer’s management with berries fruits therapy
- CURRENT Alzheimer’s MANAGEMENT WITH DIETARY SEEDS THERAPY
- Current and emerging pharmacological targets for the treatment of Alzheimer’s disease
- Current and emerging therapeutic targets of Alzheimer’s disease for the design of multi-target directed ligands
- Current and investigational drugs for treatment of Alzheimer’s disease
- Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer’s disease
- Current evidence on the effect of dietary polyphenols intake on chronic diseases
- Current opinions and perspectives on the role of immune system in the pathogenesis of Parkinson’s disease
- Current perspectives and mechanisms of relationship between intestinal microbiota dysfunction and dementia: a review
- Current pharmacotherapy and putative disease-modifying therapy for Alzheimer’s disease
- Current status of metals as therapeutic targets in Alzheimer’s disease
- Cytological profiling of natural product scaffolds libraries for Parkinson’s disease
- Cytoprotection by Achyrocline satureioides (Lam) DC and some of its main flavonoids against oxidative stress
- Cytoprotective effects of phenolic antioxidants and essential fatty acids in human blood monocyte and neuroblastoma cell lines: Surrogates for neurological damage in …
- De B. Acetylcholinesterase inhibitory properties of black tea and its polyphenolic components
- Defective insulin signalling, mediated by inflammation, connects obesity to Alzheimer disease; relevant pharmacological therapies and preventive dietary …
- dementia IN SURINAME
- Dementia, preclinical studies in neurodegeneration and its potential for translational medicine in South America
- Design and characterization of enzymatic deglycosylation systems to produce drugs against Alzheimer’s disease
- Design and development of novel irreversible GSK-3β inhibitors to address Alzheimer’s disease
- Design and Molecular dynamic investigations of 7, 8-Dihydroxyflavone Derivatives as potential neuroprotective Agents Against Alpha-synuclein
- Design and Molecular dynamic Investigations of 7, 8-Dihydroxyflavone Derivatives as Potential neuroprotective Agents Against Alpha-synuclein
- Design and systhesis of nanoparticles for therapy and imaging of Alzheimer’s disease
- Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer’s Disease
- Design, Synthesis and Biological Assessment of Ferulic Acid Derivatives as Inhibitors of β-Amyloid Oligomerization in Alzheimer’s Disease
- Design, synthesis and biological evaluation of 3-piperazinecarboxylate sarsasapogenin derivatives as potential multifunctional anti-Alzheimer agents
- Design, synthesis and biological evaluation of scutellarein derivatives as potential anti-Alzheimer’s disease candidates based on metabolic mechanism
- Design, synthesis and evaluation of 4′-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer’s disease treatment
- Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer’s disease
- Designing multi-targeted therapeutics for the treatment of Alzheimer’s disease
- Destabilization of Alzheimer’s Aβ42 protofibrils with a novel drug candidate wgx-50 by molecular dynamics simulations
- Determination of Flavonoids
- Determination of total flavonoid content of different parts of Garcinia cowa
- Development and application of nano-flavor-drug carriers in Neurodegenerative diseases
- Development and validation of analytical methods for the identification and quantification of phenolic compounds from Euterpe oleracea fruits
- Development of a grape seed polyphenolic extract with anti‐oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies
- Development of Electrochemical Sensors for the Analysis of Therapeutic Compounds and Proteases related to Alzheimer’s disease
- Development of multifunctional molecules as potential therapeutic candidates for Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis in the …
- Development of tau aggregation inhibitors for Alzheimer’s disease
- Development of technologies for the production of polyphenolic nutraceuticals from muscadine grapes and rabbiteye blueberries
- Developments with multi-target drugs for Alzheimer’s disease: an overview of the current discovery approaches
- Diabetes and Alzheimer’s disease: can tea phytochemicals play a role in prevention?